The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
Clinical trial NCT06425419 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06425419
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.